Global Guanidinoacetic Acid Market Growth 2023-2029

Global Guanidinoacetic Acid Market Growth 2023-2029

Guanidinoacetic Acid is a metabolite of glycine in which the amino group has been converted into a guanidine. Guanidinoacetic Acid is a direct precursor of creatine and is used as a supplement. Taking guanidinoacetic acid can increase muscle strength and slow muscle fatigue, etc. And add guanidinoacetic acid into fodder can make lean pig's body improve significantly.

However the metabolism of creatine from Guanidinoacetic Acid in the liver causes a depletion of methyl groups. This causes homocysteine levels to rise, which has been shown to produce cardiovascular and skeletal problems. A series of studies showed that a combination of betaine and Guanidinoacetic Acid improves the symptoms of patients with chronic illness, including heart disease, without toxicity. Betaine can provide a methyl group to glycocyamine, via methionine, for the formation of creatine. In overall, such treatment led to less fatigue, greater strength and endurance, and an improved sense of well-being. The patients with cardiac decompensation (arteriosclerosis or rheumatic disease) and congestive heart failure had improved cardiac function. The patients gained weight (improved nitrogen balance) and saw lessened symptoms of arthritis and asthma and increased libido, and those people suffering from hypertension experienced transient reduced blood pressure. Also the studies shows the increase of glucose tolerance in both diabetic subjects and subjects without diabetes.

LPI (LP Information)' newest research report, the “Guanidinoacetic Acid Industry Forecast” looks at past sales and reviews total world Guanidinoacetic Acid sales in 2022, providing a comprehensive analysis by region and market sector of projected Guanidinoacetic Acid sales for 2023 through 2029. With Guanidinoacetic Acid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Guanidinoacetic Acid industry.

This Insight Report provides a comprehensive analysis of the global Guanidinoacetic Acid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Guanidinoacetic Acid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Guanidinoacetic Acid market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Guanidinoacetic Acid and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Guanidinoacetic Acid.

The global Guanidinoacetic Acid market size is projected to grow from US$ 34 million in 2022 to US$ 46 million in 2029; it is expected to grow at a CAGR of 46 from 2023 to 2029.

The main market players are Evonik, Tiancheng Chempharm, Jiangsu Yuanyang, Hubei Yuanhua, Hebei Daxiao and GENDONE, with about 50% market shares.

This report presents a comprehensive overview, market shares, and growth opportunities of Guanidinoacetic Acid market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

Feed Grade

Pharmaceutical Grade

Others

Segmentation by application

Fodder

Medicine

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Evonik

Tiancheng Chempharm

Jiangsu Yuanyang

Hubei Yuanhua

Hebei Daxiao

GENDONE

Shijiazhuang Zexing Group

Lubon Industry

Key Questions Addressed in this Report

What is the 10-year outlook for the global Guanidinoacetic Acid market?

What factors are driving Guanidinoacetic Acid market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Guanidinoacetic Acid market opportunities vary by end market size?

How does Guanidinoacetic Acid break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.